Correlation Between Avadel Pharmaceuticals and 26444HAN1

Can any of the company-specific risk be diversified away by investing in both Avadel Pharmaceuticals and 26444HAN1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avadel Pharmaceuticals and 26444HAN1 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Avadel Pharmaceuticals PLC and DUK 595 15 NOV 52, you can compare the effects of market volatilities on Avadel Pharmaceuticals and 26444HAN1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avadel Pharmaceuticals with a short position of 26444HAN1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avadel Pharmaceuticals and 26444HAN1.

Diversification Opportunities for Avadel Pharmaceuticals and 26444HAN1

-0.04

Correlation Coefficient

Avadel Pharmaceuticals  26444HAN1

Good diversification

The 3 months correlation between Avadel and 26444HAN1 is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and DUK 595 15 NOV 52 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DUK 595 15 and Avadel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avadel Pharmaceuticals PLC are associated (or correlated) with 26444HAN1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DUK 595 15 has no effect on the direction of Avadel Pharmaceuticals i.e., Avadel Pharmaceuticals and 26444HAN1 go up and down completely randomly.

Pair Corralation between Avadel Pharmaceuticals and 26444HAN1

Given the investment horizon of 90 days Avadel Pharmaceuticals PLC is expected to under-perform the 26444HAN1. In addition to that, Avadel Pharmaceuticals is 4.23 times more volatile than DUK 595 15 NOV 52. It trades about -0.04 of its total potential returns per unit of risk. DUK 595 15 NOV 52 is currently generating about 0.03 per unit of volatility. If you would invest  10,163  in DUK 595 15 NOV 52 on December 24, 2024 and sell it today you would earn a total of  138.00  from holding DUK 595 15 NOV 52 or generate 1.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.36%
Values	Daily Returns

Avadel Pharmaceuticals PLC  vs.  DUK 595 15 NOV 52

Avadel Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

DUK 595 15

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in DUK 595 15 NOV 52 are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 26444HAN1 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Avadel Pharmaceuticals and 26444HAN1

The main advantage of trading using opposite Avadel Pharmaceuticals and 26444HAN1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avadel Pharmaceuticals position performs unexpectedly, 26444HAN1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 26444HAN1 will offset losses from the drop in 26444HAN1's long position.

The idea behind Avadel Pharmaceuticals PLC and DUK 595 15 NOV 52 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.